Related Experiment Video
Updated: Jun 18, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized
Xinmin Li1, Junzi Long2, Qian Gao2
1School of Traditional Chinese Medicine, Henan University of Chinese Medicine, 450046 Zhengzhou, Henan, China.
Nattokinase supplementation effectively reduces blood pressure, but its effect on cholesterol is dose-dependent, with low doses showing no lipid-lowering benefits. Further research is needed to clarify dose-response relationships for cardiovascular risk factors.
Area of Science:
- Cardiovascular Health
- Nutritional Biochemistry
- Pharmacology
Background:
- Nattokinase, a fibrinolytic enzyme from fermented soybean, shows potential cardiovascular benefits.
- Clinical evidence on nattokinase's impact on cardiovascular risk factors is varied.
- This study evaluates nattokinase's efficacy in managing cardiovascular health.
Purpose of the Study:
- To assess the cardiovascular efficacy of nattokinase supplementation.
- To analyze the effects of nattokinase on blood pressure, lipid profiles, and glucose levels.
- To investigate potential dose-dependent effects of nattokinase on cardiovascular risk factors.
Main Methods:
- Systematic search of four electronic databases for eligible randomized controlled trials.
- Data extraction and summarization by two independent reviewers.
- Meta-analysis and bias risk assessment using Review Manager 5.4 software.
Main Results:
- Six studies with 546 participants were included; overall quality was high.
- Nattokinase significantly reduced systolic and diastolic blood pressure.
- Low-dose nattokinase negatively impacted total, HDL, and LDL cholesterol; high-dose showed increased total cholesterol but no significant HDL/LDL changes.
- Nattokinase supplementation led to a slight increase in blood glucose; no significant effect on triglycerides was observed.
- No notable adverse events were reported.
Conclusions:
- Nattokinase is an effective adjunctive therapy for hypertension.
- Low-dose nattokinase may not provide significant lipid-lowering effects.
- Further research is required to determine if nattokinase's cardiovascular efficacy is dose-dependent.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

